Compare Gemini Space Station Inc (GEMI) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Merck & Co., Inc. — how do they compare? Gemini Space Station Inc trades at $4.41 (market cap $579.55M), while Merck & Co., Inc. trades at $142.17 (market cap $351.28B). The key difference: Merck & Co., Inc. is far larger — about 606.1× Gemini Space Station Inc's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Merck & Co., Inc. for 98 Days on average.
| GEMI | MRK | |
|---|---|---|
Market Cap | $579.55M | $351.28B |
Volume | 1,882,406 | 7,969,665 |
Sector | Financials | Health |
52-Week High | $25.41 | $156.43 |
52-Week Low | $3.54 | $82.49 |
Typical Hold Time | 14 Days | 98 Days |
Enterprise Value | $558.57M | $398.04B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.49, down 3.85% amid bearish technical signals despite recent 31% surge. The company shows concerning fundamentals with negative gross profit margin of -70.25% and net income margin of -250.13% for 2025. Revenue grew 37% YoY in Q2 2026 to $207M, but losses persist with $517M net loss. Analyst consensus is mixed with 33% buy ratings and $5.33 price target, while technical indicators show oversold conditions with RSI at 16.87.
GEMI presents high-risk speculation with significant operational challenges despite revenue growth. The stock's viability depends on reversing deep losses and achieving profitability. Near-term catalysts include SEC's tokenized stock trading pathway, but class action lawsuits and persistent cash burn pose substantial downside risk. Current valuation at 2.75 P/S appears stretched given negative margins.
Merck (MRK) trades at $142.79, up 0.61% on the day, with a bearish technical signal despite beating earnings estimates in recent quarters. The company reported 2025 revenue of $65.01B and net income of $18.25B, with a high P/E ratio of 113.9 reflecting premium valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while institutional investors have been increasing stakes.
The outlook is mixed: strong analyst consensus (68% buy ratings) and a $158.78 price target suggest upside, but high valuation and bearish technicals pose near-term risks. Key opportunities include pipeline expansion via M&A; risks involve integration challenges and patent pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
